IN2015DN00515A - - Google Patents
Info
- Publication number
- IN2015DN00515A IN2015DN00515A IN515DEN2015A IN2015DN00515A IN 2015DN00515 A IN2015DN00515 A IN 2015DN00515A IN 515DEN2015 A IN515DEN2015 A IN 515DEN2015A IN 2015DN00515 A IN2015DN00515 A IN 2015DN00515A
- Authority
- IN
- India
- Prior art keywords
- microglobulin
- alpha
- treatment
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1722—Plasma globulins, lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270538 | 2012-09-05 | ||
| DKPA201270557 | 2012-09-12 | ||
| PCT/EP2013/068270 WO2014037390A1 (en) | 2012-09-05 | 2013-09-04 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN00515A true IN2015DN00515A (da) | 2015-06-26 |
Family
ID=49162118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN515DEN2015 IN2015DN00515A (da) | 2012-09-05 | 2013-09-04 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10226507B2 (da) |
| EP (1) | EP2900254B1 (da) |
| JP (2) | JP2015533790A (da) |
| KR (1) | KR20150047510A (da) |
| CN (1) | CN104661673A (da) |
| AU (1) | AU2013311714C1 (da) |
| BR (1) | BR112015003957A2 (da) |
| CA (1) | CA2881321A1 (da) |
| DK (1) | DK2900254T3 (da) |
| EA (1) | EA028963B1 (da) |
| ES (1) | ES2599034T3 (da) |
| HK (1) | HK1210585A1 (da) |
| HR (1) | HRP20161364T1 (da) |
| HU (1) | HUE030559T2 (da) |
| IN (1) | IN2015DN00515A (da) |
| MX (1) | MX357656B (da) |
| NZ (1) | NZ629621A (da) |
| PL (1) | PL2900254T3 (da) |
| PT (1) | PT2900254T (da) |
| SG (1) | SG11201500669SA (da) |
| WO (1) | WO2014037390A1 (da) |
| ZA (1) | ZA201500547B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016204360A (ja) * | 2015-02-25 | 2016-12-08 | エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ | 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン |
| CA3014850A1 (en) * | 2016-02-25 | 2017-08-31 | A1M Pharma Ab | Alpha-1-microglobulin for use in the protection of kidneys in connection with use of contrast media |
| EA039776B1 (ru) * | 2016-03-18 | 2022-03-11 | Гард Терапьютикс Интернэшнл Айби | Новые белки, полученные из альфа-1-микроглобулина, и их применение |
| GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
| CN109867717A (zh) * | 2019-04-01 | 2019-06-11 | 山西瑞亚力生物技术有限公司 | 一种血浆中α1微球蛋白的提取方法 |
| CN110452980B (zh) * | 2019-09-23 | 2023-07-28 | 武汉儿童医院 | 一种线粒体脑肌病诊断试剂盒及应用 |
| WO2021062007A1 (en) * | 2019-09-25 | 2021-04-01 | Cytegen Corp. | Treatment of mitochondrial deficits and age-related diseases using blood products |
| CN115575646B (zh) * | 2022-11-21 | 2023-04-28 | 四川大学华西医院 | 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004292775A1 (en) * | 2003-11-26 | 2005-06-09 | Sanofi-Aventis Deutschland Gmbh | Tubular proteinuria as an indicator for elevated cardiovascular risk |
| HUE031613T2 (en) * | 2007-02-12 | 2017-09-28 | A1M Pharma Ab | Diagnosis and treatment of preeclampsia |
| HUE026750T2 (en) * | 2008-02-04 | 2016-07-28 | Yissum Res Dev Co | Methods and Preparations for the Treatment of Mitochondrial Disorders |
| PL2313106T3 (pl) | 2008-07-18 | 2016-08-31 | A1M Pharma Ab | Medyczne zastosowanie zmiatacza wolnych rodników i antyoksydantu alfa-1-mikroglobuliny |
-
2013
- 2013-09-04 NZ NZ629621A patent/NZ629621A/en not_active IP Right Cessation
- 2013-09-04 CA CA2881321A patent/CA2881321A1/en not_active Abandoned
- 2013-09-04 JP JP2015530375A patent/JP2015533790A/ja active Pending
- 2013-09-04 EP EP13759995.7A patent/EP2900254B1/en not_active Not-in-force
- 2013-09-04 BR BR112015003957A patent/BR112015003957A2/pt not_active Application Discontinuation
- 2013-09-04 PL PL13759995T patent/PL2900254T3/pl unknown
- 2013-09-04 HU HUE13759995A patent/HUE030559T2/en unknown
- 2013-09-04 CN CN201380043567.0A patent/CN104661673A/zh active Pending
- 2013-09-04 MX MX2015002604A patent/MX357656B/es active IP Right Grant
- 2013-09-04 ES ES13759995.7T patent/ES2599034T3/es active Active
- 2013-09-04 PT PT137599957T patent/PT2900254T/pt unknown
- 2013-09-04 IN IN515DEN2015 patent/IN2015DN00515A/en unknown
- 2013-09-04 SG SG11201500669SA patent/SG11201500669SA/en unknown
- 2013-09-04 AU AU2013311714A patent/AU2013311714C1/en not_active Ceased
- 2013-09-04 DK DK13759995.7T patent/DK2900254T3/da active
- 2013-09-04 KR KR1020157005748A patent/KR20150047510A/ko not_active Application Discontinuation
- 2013-09-04 US US14/423,260 patent/US10226507B2/en not_active Expired - Fee Related
- 2013-09-04 WO PCT/EP2013/068270 patent/WO2014037390A1/en active Application Filing
- 2013-09-04 EA EA201590503A patent/EA028963B1/ru not_active IP Right Cessation
-
2015
- 2015-01-23 ZA ZA2015/00547A patent/ZA201500547B/en unknown
- 2015-09-15 HK HK15109002.0A patent/HK1210585A1/xx not_active IP Right Cessation
-
2016
- 2016-10-19 HR HRP20161364TT patent/HRP20161364T1/hr unknown
-
2018
- 2018-08-24 JP JP2018157394A patent/JP2018203756A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018203756A (ja) | 2018-12-27 |
| AU2013311714A1 (en) | 2015-03-12 |
| AU2013311714B2 (en) | 2017-10-12 |
| PL2900254T3 (pl) | 2017-02-28 |
| ES2599034T3 (es) | 2017-01-31 |
| EA028963B1 (ru) | 2018-01-31 |
| AU2013311714C1 (en) | 2018-01-25 |
| MX2015002604A (es) | 2015-06-10 |
| JP2015533790A (ja) | 2015-11-26 |
| US20150258171A1 (en) | 2015-09-17 |
| SG11201500669SA (en) | 2015-02-27 |
| BR112015003957A2 (pt) | 2017-08-08 |
| CN104661673A (zh) | 2015-05-27 |
| ZA201500547B (en) | 2017-09-27 |
| HRP20161364T1 (hr) | 2016-12-16 |
| NZ629621A (en) | 2015-09-25 |
| US10226507B2 (en) | 2019-03-12 |
| EA201590503A1 (ru) | 2015-06-30 |
| PT2900254T (pt) | 2016-10-18 |
| CA2881321A1 (en) | 2014-03-13 |
| WO2014037390A1 (en) | 2014-03-13 |
| KR20150047510A (ko) | 2015-05-04 |
| HUE030559T2 (en) | 2017-05-29 |
| HK1210585A1 (en) | 2016-04-29 |
| MX357656B (es) | 2018-07-18 |
| EP2900254B1 (en) | 2016-08-03 |
| EP2900254A1 (en) | 2015-08-05 |
| DK2900254T3 (da) | 2016-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN00515A (da) | ||
| HK1222552A1 (zh) | 索布替羅用於治療髓鞘形成疾病 | |
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| HUE056006T2 (hu) | Kombináció Parkinson-kór kezelésére | |
| MX2021004211A (es) | Composiciones vacuna. | |
| MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
| AP2014007399A0 (en) | Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament | |
| EP2822558A4 (en) | PROCASPASE 3 ACTIVATION BY COMBINATION THERAPY | |
| GB2518801B (en) | Improvements in, or relating to, caskets or coffins | |
| GB201511770D0 (en) | Novel pharmaceutical formulationsand their use in the treatment of periodontal disease | |
| IL235429A0 (en) | (r)-nifortal, its use in the treatment of infections and the preparation of (r) and (s)-nifortal | |
| HK1215794A1 (zh) | 用於治療疾病的同種異體自噬體富集組合物 | |
| EP2825194A4 (en) | USE OF ANTITHROMBINE IN THE TREATMENT OF PRE-ECLAMPSIA | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| BR112015023730A2 (pt) | uso de sedoeptulose como suplemento nutricional | |
| IN2014KN01772A (da) | ||
| ZA201500652B (en) | Medicine againts gastroesephageal reflux disease | |
| CY1117740T1 (el) | Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης | |
| GB201310748D0 (en) | Student's clinic | |
| UA24322S (uk) | Стамеска пасічника | |
| FI20115180L (fi) | Koostumus käytettäväksi sairauden hoidossa | |
| UA75904U (xx) | Стоматологічний комплект "sadaf dent streg" | |
| UA80618U (en) | Use of n-steroylethanolamine as radiomodifier | |
| IN2012DE01204A (en) | "shikhar technology" | |
| MX2015001134A (es) | Compuestos terapeuticos. |